First Commonwealth Financial Corp PA held its position in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,636 shares of the insurance provider’s stock at the end of the 2nd quarter. Humana accounts for about 1.2% of First Commonwealth Financial Corp PA’s investment portfolio, making the stock its 23rd largest holding. First Commonwealth Financial Corp PA’s holdings in Humana were worth $1,115,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Guardian Life Insurance Co. of America raised its stake in shares of Humana by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after acquiring an additional 4 shares during the last quarter. Acrospire Investment Management LLC bought a new position in shares of Humana during the second quarter valued at about $120,000. Independent Portfolio Consultants Inc. raised its stake in shares of Humana by 22.1% during the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after acquiring an additional 94 shares during the last quarter. Point72 Asia Hong Kong Ltd bought a new position in shares of Humana during the first quarter valued at about $128,000. Finally, Northwestern Mutual Wealth Management Co. raised its stake in shares of Humana by 139.5% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock valued at $134,000 after acquiring an additional 325 shares during the last quarter. 95.12% of the stock is owned by institutional investors and hedge funds.

In other news, insider William Kevin Fleming sold 3,071 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total value of $770,759.58. Following the completion of the sale, the insider now owns 7,681 shares in the company, valued at approximately $1,927,777.38. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Bruce D. Broussard sold 12,000 shares of the business’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the completion of the sale, the chief executive officer now owns 80,086 shares of the company’s stock, valued at approximately $20,172,061.68. The disclosure for this sale can be found here. In the last 90 days, insiders sold 55,595 shares of company stock valued at $14,133,706. Company insiders own 0.80% of the company’s stock.

TRADEMARK VIOLATION WARNING: “First Commonwealth Financial Corp PA Has $1,115,000 Stake in Humana Inc. (HUM)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/10/06/first-commonwealth-financial-corp-pa-has-1115000-stake-in-humana-inc-hum.html.

Shares of Humana Inc. (NYSE:HUM) traded up 0.70% during midday trading on Friday, reaching $247.07. 252,031 shares of the company’s stock were exchanged. The company has a market cap of $35.71 billion, a price-to-earnings ratio of 20.32 and a beta of 0.86. Humana Inc. has a 12-month low of $163.50 and a 12-month high of $259.76. The stock’s 50 day moving average price is $249.11 and its 200 day moving average price is $234.09.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating the consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The business had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter in the previous year, the business posted $2.30 EPS. Equities analysts anticipate that Humana Inc. will post $11.55 earnings per share for the current fiscal year.

The firm also recently declared a dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 29th will be issued a $0.40 dividend. The ex-dividend date is Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.

HUM has been the subject of several recent analyst reports. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a research note on Wednesday, August 23rd. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 price objective for the company in a research note on Friday, June 9th. Morgan Stanley upped their price objective on shares of Humana from $269.00 to $276.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Finally, Cowen and Company reaffirmed an “outperform” rating and set a $275.00 price objective (up from $230.00) on shares of Humana in a research note on Wednesday, September 20th. Nine research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $247.50.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.